Asbestosis

Asbestosis is a chronic, progressive interstitial lung disease caused by the inhalation and retention of asbestos fibers in the lung parenchyma. Asbestos is a naturally occurring silicate mineral that was widely used in construction, insulation, shipbuilding, automotive brakes, and industrial manufacturing due to its heat resistance, tensile strength, and insulating properties. When asbestos-containing materials are disturbed, microscopic fibers become airborne and can be inhaled deep into the respiratory tract. There are two main fiber types: serpentine fibers (chrysotile, which is curved and more easily cleared) and amphibole fibers (amosite, crocidolite, tremolite, which are straight, needle-like, and more pathogenic). The inhaled fibers penetrate to the terminal bronchioles and alveoli, where alveolar macrophages attempt to engulf them. However, amphibole fibers are too long (greater than 20 micrometers) for complete phagocytosis, a phenomenon called frustrated phagocytosis. The macrophages release reactive oxygen species, proteolytic enzymes, and fibrogenic growth factors (transforming growth factor-beta, platelet-derived growth factor) in an attempt to destroy the fibers. This persistent inflammatory response activates fibroblasts, which deposit excessive collagen in the alveolar interstitium, causing progressive interstitial fibrosis. The fibrosis thickens the alveolar-capillary membrane, impairing gas diffusion and producing the characteristic restrictive lung disease pattern. Fibrosis typically begins in the lower lobes and progresses upward, distinguishing asbestosis from silicosis (which affects upper lobes first). Asbestos bodies (golden-brown, dumbbell-shaped structures visible on microscopy) form when macrophages coat asbestos fibers with iron-containing protein (ferritin and hemosiderin) and are considered a hallmark pathological finding. Pleural plaques -- discrete areas of hyalinized collagen on the parietal pleura, often calcified -- are the most common manifestation of asbestos exposure and serve as a radiographic marker, though they themselves rarely cause symptoms. The latency period between initial exposure and disease manifestation is typically 15-20 years or longer. Critically, asbestos exposure significantly increases the risk of malignant mesothelioma (a cancer of the pleural or peritoneal mesothelium that is almost exclusively caused by asbestos, with a latency of 20-40 years) and bronchogenic carcinoma (lung cancer risk is multiplicative when combined with smoking: asbestos alone increases risk 5-fold, smoking alone 10-fold, but the combination increases risk 50-fold). There is no cure for asbestosis; treatment is supportive, focusing on symptom management, prevention of complications, and surveillance for malignancy.